Johnson Samantha, Marlow Neil
Academic Division of Child Health, E Floor, East Block, Queen's Medical Centre, Nottingham, NG7 2UH, United Kingdom.
Early Hum Dev. 2006 Mar;82(3):173-83. doi: 10.1016/j.earlhumdev.2006.01.008. Epub 2006 Feb 28.
Given the high risk for residual disability in preterm infants, outcome monitoring is a crucial function of neonatal care. Provision of neurodevelopmental follow-up to at least 2 years of age corrected for prematurity forms part of national recommendations for neonatal services. This should include a developmental assessment at 2 years to identify disability. Although screening tools are cost and time efficient measures, they are not diagnostic and have less utility in high-risk populations. In contrast, standardised developmental tests are ideally suited for follow-up purposes and have become widely accepted as outcome measures. We highlight the properties of standardised tests and review the most commonly used tools for assessment in infancy. We also outline a number of practical issues in the use of standardised tests with preterm infants in identifying morbidity and predicting later impairment. Parental reports are also discussed and key guidelines for developmental testing at 2 years are provided.
鉴于早产儿存在残留残疾的高风险,结果监测是新生儿护理的一项关键功能。为早产矫正年龄至少2岁的婴儿提供神经发育随访是国家新生儿服务建议的一部分。这应包括在2岁时进行发育评估以确定残疾情况。尽管筛查工具是具有成本效益和省时的措施,但它们并非诊断性工具,在高危人群中的效用较低。相比之下,标准化发育测试非常适合随访目的,并且已被广泛接受为结果测量方法。我们强调标准化测试的特性,并回顾婴儿期评估最常用的工具。我们还概述了在对早产儿使用标准化测试以识别发病情况和预测后期损伤时的一些实际问题。还讨论了家长报告,并提供了2岁时发育测试的关键指南。